Positive correlation between pregnancy-associated plasma protein-A level and OX40 ligand expression in patients with acute coronary syndromes

Biomedicine and Pharmacotherapy

Volumn 65, Issue 3, 2011, Pages 193-197

  Liu, Peijing ^a   Yan, Jinchuan ^a   Gong, Jie ^a   Wang, Cuiping ^a   Chen, Guanghua ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Complex coronary stenosis; Coronary disease; OX40 ligand; Ruptured plaque

Indexed keywords

OX40 LIGAND; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; OX40 LIGAND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 79959634096     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.10.011     Document Type: Article

References (22)

1. Apple F.S., Wu A.H., Mair J., Ravkilde J., Panteghini M., Tate J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005, 51:810-824.
2. Wu A.H. Markers for early detection of cardiac diseases. Scand J Clin Lab Invest 2005, 240:112-121. [Review].
3. Liu D.M., Yan J.C., Wang C.P., Chen G.H., Ding S., Liu P.J., et al. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta 2008, 397(1-2):22-26.
4. Qin Q.P., Wittfooth S., Pettersson K. Measurement and clinical significance of circulating PAPP-A in ACS patients. Clin Chim Acta 2007, 380:59-67.
5. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes D.R., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001, 345:1022-1029.
6. Iversen K.K., Dalsgaard M., Teisner A.S., Schoos M., Teisner B., Nielsen H., et al. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome. Am J Cardiol 2009, 104(11):1465-1471.
7. Iversen K.K., Teisner A.S., Teisner B., Kliem A., Thanning P., Nielsen H., et al. Pregnancy-associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem 2009, 42(9):828-834.
8. Brügger-Andersen T., Aarsetøy H., Grundt H., Staines H., Nilsen D.W. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thromb Res 2008, 123(1):60-66.
9. Ria M., Eriksson P., Boquist S., Ericsson C.G., Hamsten A., Lagercrantz J. Human genetic evidence that OX40 is implicated in myocardial infarction. Biochem Biophys Res Com 2006, 339:1001-1006.
10. Wang X., Ria M., Kelmenson P.M., Eriksson P., Higgins D.C., Samnegård A., et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 2005, 37:365-372.
11. Macdonald S.L., Kilpatrick D.C. Human serum amyloid P component binds to peripheral blood monocytes. Scand J Immunol 2006, 64(1):48-52.
12. Kaski J.C., Chester M.R., Chen L., Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 1995, 92:2058-2065.
13. Kai H., Ikeda H., Yasukawa H., Kai M., Seki Y., Kuwahara F., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998, 32:368-372.
14. Inokubo Y., Hanada H., Ishizaka H., Fukushi T., Kamada T., Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001, 141:211-217.
15. Oxvig C., Sand O., Kristensen T., Kristensen L., Sottrup-Jensen L. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta 1994, 1201:415-423.
16. Lawrence J.B., Oxvig C., Overgaard M.T., Sottrup-Jensen L., Gleich G.J., Hays L.G., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 1999, 96:3149-3153.
17. Cosin-Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., Cole D., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004, 109:1724-1728.
18. Lund J., Qin Q.P., Ilva T., Pettersson K., Voipio-Pulkki L.M., Porela P., et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003, 108:1924-1926.
19. Yan J., Chen G., Gong J., Wang C., Du R. Upregulation of OX40-OX40 ligand system on T lymphocytes in patients with acute coronary syndromes. J Cardiovasc Pharmacol 2009, 54(5):451-455.
20. Wilson R.F., Holida M.D., White C.W. Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation 1986, 73:286-293.
21. Divies M.J. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996, 94:2013-2020.
22. Schroeder A.P., Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis 1995, 118:S141-S149.